Surgery for multiple hepatic colorectal metastases.

Norihiro Kokudo, Hiroshi Imamura, Yasuhiko Sugawara, Yoshihiro Sakamoto, Junji Yamamoto, Makoto Seki, Masatoshi Makuuchi
{"title":"Surgery for multiple hepatic colorectal metastases.","authors":"Norihiro Kokudo,&nbsp;Hiroshi Imamura,&nbsp;Yasuhiko Sugawara,&nbsp;Yoshihiro Sakamoto,&nbsp;Junji Yamamoto,&nbsp;Makoto Seki,&nbsp;Masatoshi Makuuchi","doi":"10.1007/s00534-002-0754-2","DOIUrl":null,"url":null,"abstract":"<p><p>The purpose of this review is to address three important questions concerning hepatic resection for multiple colorectal metastases. (1) Is the number of tumors truly a significant prognostic factor? (2) Are patients with four or more tumors contraindicated for hepatic resection? (3) Up to how many nodules should we attempt to resect? Although the efficacy of surgical resection for one to three hepatic metastases is clear, based on several reports, the literature regarding the resection of four or more metastatic lesions is conflicting. Review of the data at our institutions showed that the number of tumors was a significant prognostic factor, because patient survival after liver resection for multiple metastases was worse than that for single metastasis. However, patients with two or three nodules and those with four or more nodules showed the same survival curves, or those with four or more metastases fared even better. Therefore, patients with four or more metastases should be considered for hepatic resection. The maximum number of hepatic tumors in longterm survivors reported in the literature has been increasing, and the limit for the number of respectable metastases has not yet been determined. Because liver resection is still the only treatment that offers a cure, surgery for multiple metastases may be justified as long as the operation is safe and technically feasible.</p>","PeriodicalId":15992,"journal":{"name":"Journal of hepato-biliary-pancreatic surgery","volume":"11 2","pages":"84-91"},"PeriodicalIF":0.0000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00534-002-0754-2","citationCount":"68","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of hepato-biliary-pancreatic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00534-002-0754-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 68

Abstract

The purpose of this review is to address three important questions concerning hepatic resection for multiple colorectal metastases. (1) Is the number of tumors truly a significant prognostic factor? (2) Are patients with four or more tumors contraindicated for hepatic resection? (3) Up to how many nodules should we attempt to resect? Although the efficacy of surgical resection for one to three hepatic metastases is clear, based on several reports, the literature regarding the resection of four or more metastatic lesions is conflicting. Review of the data at our institutions showed that the number of tumors was a significant prognostic factor, because patient survival after liver resection for multiple metastases was worse than that for single metastasis. However, patients with two or three nodules and those with four or more nodules showed the same survival curves, or those with four or more metastases fared even better. Therefore, patients with four or more metastases should be considered for hepatic resection. The maximum number of hepatic tumors in longterm survivors reported in the literature has been increasing, and the limit for the number of respectable metastases has not yet been determined. Because liver resection is still the only treatment that offers a cure, surgery for multiple metastases may be justified as long as the operation is safe and technically feasible.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
手术治疗多发性肝结直肠转移。
这篇综述的目的是解决三个重要的问题有关肝切除多发性结肠直肠癌转移。(1)肿瘤数量真的是一个重要的预后因素吗?(2)有4个或更多肿瘤的患者是否忌讳肝切除术?(3)我们应该切除多少个结节?虽然手术切除一到三个肝转移灶的疗效是明确的,但根据几篇报道,关于切除四个或更多转移灶的文献是相互矛盾的。回顾我们机构的数据显示,肿瘤的数量是一个重要的预后因素,因为多发性转移的患者在肝切除术后的生存率比单一转移的患者差。然而,有两个或三个结节的患者和有四个或更多结节的患者表现出相同的生存曲线,或者有四个或更多转移的患者表现更好。因此,有四个或更多转移灶的患者应考虑肝切除。文献中报道的长期幸存者中肝脏肿瘤的最大数量一直在增加,而值得注意的转移数量的限制尚未确定。由于肝切除仍然是唯一能够治愈的治疗方法,因此只要手术安全且技术可行,对多发性转移的手术可能是合理的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Laparoscopic-assisted limited liver resection: technique, indications and results. Laparoscopic major hepato-biliary-pancreatic surgery: formidable challenge to standardization. Tokyo Guidelines for the management of acute cholangitis and cholecystitis. Proceedings of a consensus meeting, April 2006, Tokyo, Japan. Treatment outcome of selective digestive decontamination and enteral nutrition in patients with severe acute pancreatitis. Protective effects of a hibernation-inducer on hepatocyte injury induced by hypothermic preservation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1